Evidence map›Paper›PMID 42769789›Full record

SynthesisOncology research2026

Immunotherapy in Bellini Duct Carcinoma: A Systematic Review.

Antonio David Lázaro-Sánchez, Javier David Benítez-Fuentes, Sofía Wikström-Fernández, María Nevado-Rodríguez, Pablo Conesa-Zamora, Ginés Luengo-Gil, Alejandra Ivars-Rubio, Marta Zafra-Poves, Edgardo D Carosella, Belén Fernández-Molina and 3 more

Abstract readSystematic ReviewReview
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Antonio David Lázaro-SánchezDepartment of Medical Oncology, University Clinical Hospital Virgen de la Arrixaca, Murcia, Spain.
Javier David Benítez-FuentesDepartment of Medical Oncology, Elche General University Hospital, Alicante, Spain.
Sofía Wikström-FernándezDepartment of Medical Oncology, Santa Lucia General University Hospital, Cartagena, Spain.
María Nevado-RodríguezDepartment of Medical Oncology, Morales Meseguer General University Hospital, Murcia, Spain.
Pablo Conesa-ZamoraGroup of Molecular Pathology and Pharmacogenetics, Biomedical Research Institute from Murcia (IMIB), Laboratory Medicine and Pathology Department, Santa Lucía General University Hospital, Cartagena, Spain.
Ginés Luengo-GilGroup of Molecular Pathology and Pharmacogenetics, Biomedical Research Institute from Murcia (IMIB), Laboratory Medicine and Pathology Department, Santa Lucía General University Hospital, Cartagena, Spain.
Alejandra Ivars-RubioDepartment of Medical Oncology, Morales Meseguer General University Hospital, Murcia, Spain.
Marta Zafra-PovesDepartment of Medical Oncology, Morales Meseguer General University Hospital, Murcia, Spain.
Edgardo D CarosellaCEA, DRF-Institut de Biologie François Jacob, Service de Recherches en Hémato-Immunologie, Hôpital Saint-Louis, Paris, France.
Belén Fernández-MolinaFamily and Community Medicine, Lorenzo Guirao Hospital, Murcia, Spain.
Andrés Nieto-OlivaresDepartment of Pathological Anatomy, Morales Meseguer General University Hospital, Murcia, Spain.
María José Sánchez de Las Matas GarreDepartment of Pathological Anatomy, Santa Lucía General University Hospital, Cartagena, Spain.
Ana Belén ArroyoGroup of Molecular Pathology and Pharmacogenetics, Biomedical Research Institute from Murcia (IMIB), Laboratory Medicine and Pathology Department, Santa Lucía General University Hospital, Cartagena, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellImmune Checkpoint InhibitorsImmunotherapyKidney NeoplasmsHumansImmune Checkpoint InhibitorsBellini duct carcinomaCollecting duct carcinomaimmunotherapyPD-1/PD-L1 blockadesystematic review

Identifiers

PMID42769789
PMCPMC13591354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.